Vital Chemtech Limited Announces Audited Financial Results for FY26
Vital Chemtech Limited reported audited standalone Net Profit of ₹245.82 lakhs for Q4FY26 and ₹896.26 lakhs for FY26. Consolidated Net Profit was ₹86.00 lakhs for Q4FY26 and ₹104.42 lakhs for FY26. The results were approved by the Board on May 29, 2026.
The announcement concerns the audited financial results for the full year and the latest quarter, which are material information for investors. The mixed performance, particularly the decrease in consolidated profit, could influence investor decisions.
The announcement reports financial results which show a mixed performance with a significant increase in standalone profit but a decrease in consolidated profit year-on-year for the quarter. This warrants a neutral sentiment.
Vital Chemtech Limited has announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The results were published on May 30, 2026, in The Financial Express (English and Gujarati editions) and are also available on the company's website.
The company reported a Net Profit of ₹245.82 lakhs for the standalone quarter ended March 31, 2026, compared to ₹156.73 lakhs in the same period last year. For the full year ended March 31, 2026, the standalone Net Profit stood at ₹896.26 lakhs.
On a consolidated basis, the Net Profit for the quarter ended March 31, 2026, was ₹86.00 lakhs, a decrease from ₹117.40 lakhs in the corresponding quarter of the previous year. The consolidated Net Profit for the full year ended March 31, 2026, was ₹104.42 lakhs.
The Board of Directors approved these results on May 29, 2026, following a review by the Audit Committee. The company also noted its migration to the Main Board of NSE from the SME Platform effective March 11, 2026, and its adoption of Ind AS from April 1, 2025.
What to do with a filing like this
Vital Chemtech Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vital Chemtech Limited. Read the original for the full detail.